• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 4 of 100
Novo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee
FinanceNovo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee
By Jason MaJune 17, 2025
man using AI technology on a computer
NewslettersPharma tech CFO says finance is at the center of AI strategy
By Sheryl EstradaMay 23, 2025
Top Chinese drugmaker Hengrui soars in Hong Kong trading debut
FinanceTop Chinese drugmaker Hengrui soars in Hong Kong trading debut
By Amber Tong and BloombergMay 23, 2025
resident Donald Trump speaks during a swearing-in ceremony for new U.S. Ambassador to China David Perdue in the Oval Office at the White House on May 07, 2025 in Washington, DC.
FinanceDon’t be fooled by deescalation, says UBS, Trump’s ‘surgical increases’ on specific sectors are yet to come 
By Eleanor PringleMay 15, 2025
Mark Cuban launched Cost Plus Drugs after Republican friends asked for an alternative to Obamacare
LifestyleMark Cuban launched Cost Plus Drugs after Republican friends asked for an alternative to Obamacare
By Ani FreedmanMay 14, 2025
Trump blames ‘brutal’ Europe for soaring drug costs in bid to curb U.S. prices
PoliticsTrump blames ‘brutal’ Europe for soaring drug costs in bid to curb U.S. prices
By AFPMay 13, 2025
Trump says new executive order limiting drug costs to what other countries pay will cut prices 30%-80% ‘immediately’
HealthTrump says new executive order limiting drug costs to what other countries pay will cut prices 30%-80% ‘immediately’
By Will Weissert, Amanda Seitz and The Associated PressMay 12, 2025
Trump seeks to match US drug costs with cheaper ones abroad
PoliticsTrump seeks to match US drug costs with cheaper ones abroad
By Derek Wallbank and BloombergMay 11, 2025
Karsten Munk Knudsen, chief financial officer of Novo Nordisk A/S, at the company's headquarters in Bagsvaerd, Denmark, on Tuesday, Nov. 26, 2024.
HealthCurrency hedging and new U.S. factories: Novo Nordisk CFO thinks Wegovy maker can outmaneuver global trade wars
By Ryan HoggMay 9, 2025
Shipping containers in port of Los Angeles
EconomyU.S. trade deficit widens to a record on pre-tariff drug imports
By Mark Niquette and BloombergMay 6, 2025
A man leans over and reaches for a bottle while standing in front of a shelf on medications.
EconomyTariffs threaten a pharmaceuticals shortage, as 95% of ibuprofen comes from China
By Sasha RogelbergApril 30, 2025
People walking by Viagra Connect ad seen in The Boots Pharmacy window in Dublin during Level 5 Covid-19 lockdown. On Thursday, 28 January, 2021, in Dublin, Ireland.
PoliticsViagra and Mounjaro panic-buying could be behind a 200% export surge from Ireland to the U.S.
By Ryan HoggApril 30, 2025
AstraZeneca CEO hopes U.S. will represent half of company’s global revenue by 2030—vows to invest and expand in nation despite tariff threat
FinanceAstraZeneca CEO hopes U.S. will represent half of company’s global revenue by 2030—vows to invest and expand in nation despite tariff threat
By AFPApril 29, 2025
Pharma giant Merck expects Trump’s tariffs to cost the company $200 million
HealthPharma giant Merck expects Trump’s tariffs to cost the company $200 million
By Maia Anderson and Healthcare BrewApril 25, 2025
A man walks next to a sign for the Roche Holding AG headquarters on April 11, 2025 in Basel, Switzerland. Before US President Donald Trump postponed a range of imminent tariffs, Switzerland was facing a daunting 31% levy on most Swiss goods to imported to the United States, a higher rate than would have been imposed on European Union countries. Such a tariff would've been high damaging to iconic Swiss industries like chocolate and watchmaking. The reprieve will provide breathing room for Swiss officials looking to negotiate a deal with the US, although Swiss goods will still face a 10% tariff in the meantime, and the fate of a potential separate tariff on pharmaceuticals is unknown.
HealthSwiss drugmaker Roche leans into Trump tariff formula with $50 billion promise to invest in U.S.
By Ryan HoggApril 22, 2025
1
  • 2
  • 3
  • 4
  • 5
  • 6
...100
Most Popular
Success
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cupplaceholder alt text
By Orianna Rosa RoyleJune 23, 2026
Banking
Markets tumble worldwide as Fed resets expectations: $400 billion wiped off SpaceX stockplaceholder alt text
By Jim EdwardsJune 23, 2026
Investing
Meet the 2 men putting New York's $300 billion pension fund in play for the first time in 20 yearsplaceholder alt text
By Nick LichtenbergJune 22, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.